These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 34459399

  • 1. Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    Bommarito G, Van De Ville D, Frisoni GB, Garibotto V, Ribaldi F, Stampacchia S, Assal F, Allali G, Griffa A.
    J Alzheimers Dis; 2021; 83(4):1717-1728. PubMed ID: 34459399
    [Abstract] [Full Text] [Related]

  • 2. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K, Ko PW, Jin M, Suk K, Lee HW.
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [Abstract] [Full Text] [Related]

  • 3. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H, Kanemoto H, Yoshiyama K, Kishima H, Suzuki Y, Sato S, Suehiro T, Azuma S, Yoshimine T, Tanaka T.
    J Neurol Sci; 2016 Oct 15; 369():236-241. PubMed ID: 27653897
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Forget About Memory: Disentangling the Amnestic Syndrome in Idiopathic Normal Pressure Hydrocephalus.
    Lingenberg A, Herrmann FR, Armand S, Péron J, Assal F, Allali G.
    J Alzheimers Dis; 2024 Oct 15; 101(4):1205-1216. PubMed ID: 39302366
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    Manniche C, Hejl AM, Hasselbalch SG, Simonsen AH.
    J Alzheimers Dis; 2019 Oct 15; 68(1):267-279. PubMed ID: 30741681
    [Abstract] [Full Text] [Related]

  • 10. Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus.
    Azuma S, Kazui H, Kanemoto H, Suzuki Y, Sato S, Suehiro T, Matsumoto T, Yoshiyama K, Kishima H, Shimosegawa E, Tanaka T, Ikeda M.
    Psychogeriatrics; 2019 Nov 15; 19(6):527-538. PubMed ID: 30916850
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    Jingami N, Uemura K, Asada-Utsugi M, Kuzuya A, Yamada S, Ishikawa M, Kawahara T, Iwasaki T, Atsuchi M, Takahashi R, Kinoshita A.
    J Alzheimers Dis; 2019 Nov 15; 72(1):271-277. PubMed ID: 31561378
    [Abstract] [Full Text] [Related]

  • 13. Increased Cerebrospinal Fluid Levels of Soluble Triggering Receptor Expressed on Myeloid Cells 2 and Chitinase-3-Like Protein 1 in Idiopathic Normal-Pressure Hydrocephalus.
    Yang F, Yang L, Fang X, Deng Y, Mao R, Yan A, Wei W.
    J Alzheimers Dis; 2023 Nov 15; 93(4):1341-1354. PubMed ID: 37182875
    [Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid Aβ42, t-tau, and p-tau levels in the differential diagnosis of idiopathic normal-pressure hydrocephalus: a systematic review and meta-analysis.
    Chen Z, Liu C, Zhang J, Relkin N, Xing Y, Li Y.
    Fluids Barriers CNS; 2017 May 10; 14(1):13. PubMed ID: 28486988
    [Abstract] [Full Text] [Related]

  • 15. CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
    Jeppsson A, Wikkelsö C, Blennow K, Zetterberg H, Constantinescu R, Remes AM, Herukka SK, Rauramaa T, Nagga K, Leinonen V, Tullberg M.
    J Neurol Neurosurg Psychiatry; 2019 Oct 10; 90(10):1117-1123. PubMed ID: 31167811
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of coexistence of Alzheimer's disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers.
    Lim TS, Choi JY, Park SA, Youn YC, Lee HY, Kim BG, Joo IS, Huh K, Moon SY.
    BMC Neurol; 2014 Apr 01; 14():66. PubMed ID: 24690253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    Kuroda T, Honma M, Mori Y, Futamura A, Sugimoto A, Kasai H, Yano S, Hieda S, Kasuga K, Ikeuchi T, Ono K.
    J Alzheimers Dis; 2022 Apr 01; 85(2):851-862. PubMed ID: 34864676
    [Abstract] [Full Text] [Related]

  • 19. Revisiting the Cerebrospinal Fluid Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus: The Bologna Pro-Hydro Study.
    Abu-Rumeileh S, Giannini G, Polischi B, Albini-Riccioli L, Milletti D, Oppi F, Stanzani-Maserati M, Capellari S, Mantovani P, Palandri G, Cortelli P, Cevoli S, Parchi P.
    J Alzheimers Dis; 2019 Apr 01; 68(2):723-733. PubMed ID: 30883350
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of amyloid PET scan in normal pressure hydrocephalus.
    Jang H, Park SB, Kim Y, Kim KW, Lee JI, Kim ST, Lee KH, Kang ES, Choe YS, Seo SW, Kim HJ, Kim YJ, Yoon CW, Na DL.
    J Neurol; 2018 Jan 01; 265(1):63-73. PubMed ID: 29128930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.